Refractory depression – cost-effectiveness of radically open dialectical behaviour therapy: findings of economic evaluation of RefraMED trial

ro_dbtpapercliniciantier 3link ok

Open source

Overview

AI-generated summary, not a substitute for reading the source.

This economic evaluation assesses the cost-effectiveness of adding radically open dialectical behaviour therapy (RO DBT) to treatment as usual for refractory depression within the UK National Health Service. The study compares net costs and quality-adjusted life-years (QALYs) between the combined intervention and standard care alone over a 12-month period. Results indicate that the incremental cost per QALY exceeds established thresholds, suggesting the resource-intensive format is not cost-effective under current conditions.

ID
88133491bd7c48ea
Source org
PubMed Central
Author
Not recorded
Published
Not recorded
OA status
Not recorded
DOI
10.1192/bjo.2019.57
PMID
Not recorded
PMCID
PMC6669879
Citations
Not recorded

Tags

Verification

Automated checks only, not clinical endorsement or advice.

Cite this entry

BibTeX

@article{allodium:88133491bd7c48ea,
  title = {Refractory depression – cost-effectiveness of radically open dialectical behaviour therapy: findings of economic evaluation of RefraMED trial},
  journal = {PubMed Central},
  doi = {10.1192/bjo.2019.57},
  url = {https://doi.org/10.1192/bjo.2019.57}
}

RIS

TY  - JOUR
TI  - Refractory depression – cost-effectiveness of radically open dialectical behaviour therapy: findings of economic evaluation of RefraMED trial
PB  - PubMed Central
DO  - 10.1192/bjo.2019.57
UR  - https://doi.org/10.1192/bjo.2019.57
ER  -

APA

Refractory depression – cost-effectiveness of radically open dialectical behaviour therapy: findings of economic evaluation of RefraMED trial. (n.d.). PubMed Central. https://doi.org/10.1192/bjo.2019.57

Related entries

More like this